cystic fibrosis

Boehringer and partners commence gene therapy trial for cystic fibrosis
Clinical Trials Arena
Fri, 02/21/25 - 10:49 am
Boehringer Ingelheim
gene therapy
cystic fibrosis
clinical trials
Vertex challenger Sionna prices $191M IPO
BioPharma Dive
Thu, 02/6/25 - 10:52 pm
Sionna Therapeutics
IPOs
cystic fibrosis
Sionna eyes up $156M IPO to fund cystic fibrosis trials
Fierce Biotech
Mon, 02/3/25 - 11:47 am
Sionna Therapeutics
IPOs
cystic fibrosis
Sionna, Odyssey join queue of biotechs testing investors’ IPO interest
BioPharma Dive
Tue, 01/21/25 - 11:16 am
IPOs
Sionna Therapeutics
cystic fibrosis
Odyssey Therapeutics
ulcerative colitis
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
BioPharma Dive
Thu, 01/2/25 - 11:35 am
FDA
Vertex Pharmaceuticals
Novo Nordisk
Bristol Myers Squibb
Alyftrek
cystic fibrosis
Alhemo
hemophilia
Opdivo Qvantiq
solid tumors
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
Yahoo/Reuters
Mon, 11/4/24 - 06:58 pm
Vertex Pharmaceuticals
earnings
cystic fibrosis
Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex
BioPharma Dive
Tue, 07/16/24 - 12:06 pm
Sionna Therapeutics
cystic fibrosis
AbbVie
Vertex Pharmaceuticals
Vertex clinches Trikafta and other cystic fibrosis drug reimbursement deal in England
Fierce Pharma
Fri, 06/21/24 - 11:42 am
Vertex Pharmaceuticals
UK
NHS
Trikafta
Symkevi
Orkambi
cystic fibrosis
enGene drops preclinical cystic fibrosis program to strengthen bladder cancer strategy
Fierce Biotech
Fri, 06/14/24 - 11:13 am
enGene
bladder cancer
cystic fibrosis
Vertex files FDA approval ask for next-gen cystic fibrosis candidate, resumes diabetes cell therapy trial
Fierce Biotech
Tue, 05/7/24 - 11:14 am
Vertex Pharmaceuticals
cystic fibrosis
Vanza Triple
FDA
gene therapy
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
Reuters
Mon, 05/6/24 - 05:53 pm
Vertex Pharmaceuticals
earnings
cystic fibrosis
BiomX acquires fellow bacteria-killing virus company Adaptive Phage to accelerate phase 2 plans
Fierce Biotech
Wed, 03/6/24 - 11:26 am
BiomX
Adaptive Phage Therapeutics
M&A
cystic fibrosis
Intellia, ReCode partner on genetic medicines for cystic fibrosis
BioPharma Dive
Thu, 02/15/24 - 11:33 am
Intellia Therapeutics
cystic fibrosis
ReCode
genetic medicine
Vertex's triple combo cystic-fibrosis drug meets main late-stage study goals
Reuters
Mon, 02/5/24 - 10:57 pm
Vertex Pharmaceuticals
cystic fibrosis
clinical trials
Vanza Triple
Where Will Vertex Pharmaceuticals Be in 10 Years?
Motley Fool
Mon, 12/4/23 - 09:31 am
Vertex Pharmaceuticals
cystic fibrosis
exa-cel
sickle cell disease
ReCode Raises $260M in Series B Financing to Advance Lead Programs
BioSpace
Wed, 09/20/23 - 11:04 pm
ReCode Therapeutics
funding
primary ciliary dyskinesia
cystic fibrosis
Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength
Yahoo/Reuters
Wed, 08/2/23 - 10:18 am
Vertex Pharmaceuticals
cystic fibrosis
earnings
ReCode, Vertex and 4DMT Seek to Help Untreated Cystic Fibrosis Patients
BioSpace
Mon, 06/5/23 - 09:57 am
cystic fibrosis
ReCode
Vertex Pharmaceuticals
4DMT
First Wave completes patient screening in trial of cystic fibrosis therapy
Clinical Trials Arena
Mon, 05/15/23 - 09:55 am
First Wave Biopharma
adrulipase
clinical trials
cystic fibrosis
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Motley Fool
Thu, 05/11/23 - 10:55 am
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
infants

Pages